Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: Prognostic and diagnostic significance

Infection

Volumn 40, Issue 3, 2012, Pages 303-309

  Lipinska Gediga, M ^a   Mierzchala, M ^a   Durek, G ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Pro atrial natriuretic peptide (pro ANP); Procalcitonin (PCT); Septic shock; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE AGENT; NATRIURETIC FACTOR; PRO ATRIAL NATRIURETIC FACTOR; PROCALCITONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; FEMALE; FLUID RESUSCITATION; HORMONE BLOOD LEVEL; HUMAN; MALE; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SURVIVOR;

ADOLESCENT; ADULT; AGED, 80 AND OVER; APACHE; ATRIAL NATRIURETIC FACTOR; BACTERIA; BIOLOGICAL MARKERS; FEMALE; FUNGI; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLAND; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; YOUNG ADULT;

EID: 84864288811     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0235-0     Document Type: Article

References (25)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus. Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
2. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928-48.
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31: 1250-6.
4. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care. 2003;7: 130-8.
5. Ince C. Microcirculation in distress: a new resuscitation end point? Crit Care Med. 2004;32:1963-4.
6. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res. 2006;69:318-28.
7. Misono KS. Natriuretic peptide receptor: structure and signaling. Mol Cell Biochem. 2002;230:49-60.
8. Misono KS, Ogawa H, Qiu Y, Ogata CM. Structural studies of the natriuretic peptide receptor: a novel hormone-induced rotation mechanism for transmembrane signal transduction. Peptides. 2005;26:957-68.
9. Vollmar AM. The role of atrial natriuretic peptide in the immune system. Peptides. 2005;26:1086-94.
10. Wiedermann CJ, Niedermühlbichler M, Braunsteiner H. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest. 1992;89:1580-6.
11. Ladetzki-Baehs K, Keller M, Kiemer AK, Koch E, Zahler S, Wendel A, Vollmar AM. Atrial natriuretic peptide, a regulator of nuclear factor-jB activation in vivo. Endocrinology. 2007;148: 332-6.
12. Becker KL, Nylén ES, White JC, Müller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004; 89:1512-25.
13. Müller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly. 2001;131: 595-602.
14. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med. 2000;26:1193-200.
15. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003.
16. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83. doi:10.1186/cc7903.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707-10.
19. Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Müller B, Schuetz P. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short-and long-term outcomes in respiratory tract infections: a prospective validation study. Int J Cardiol. 2010. Nov 18. [Epub ahead of print]
20. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care. 2005;9:R37-45.
21. Boeck L, Eggimann P, Smyrnios N, Pargger H, Thakkar N, Siegemund M, Marsch S, Rakic J, Tamm M, Stolz D. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP. Eur Respir J. 2011;37:595-603. doi: 10.1183/09031936.00023810.
22. Průha M, Zazula R, Dubska L, Sedláčková L, Kavka B. Proatria 'lní natriureticky' peptid u pacientů v sepsi, těžké sepsi a septickém šoku. Klin Biochem Metab. 2007;15:127-31.
23. Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med. 2004;32:1166-9.
24. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302:1059-66.
25. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsisassociated left ventricular dysfunction. Intensive Care Med. 2003;29:1696-702.